Cargando…

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation

Esophageal cancer is the sixth leading cause of cancer death worldwide, and patients who are treated with surgery alone, without neoadjuvant therapies, experience frequent relapses. Whether postoperative therapies could reduce the recurrence or improve overall survival is still controversial for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yingming, Li, Minghuan, Kong, Li, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948697/ https://www.ncbi.nlm.nih.gov/pubmed/27471393 http://dx.doi.org/10.2147/OTT.S104221

Ejemplares similares

Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review
por: Zhao, Fen, et al.
Publicado: (2016)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

The expression of p‐p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance
por: Wang, Zhe, et al.
Publicado: (2019)

Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
por: Zhang, Jingze, et al.
Publicado: (2018)

Identification of risk factors and the pattern of lower cervical lymph node metastasis in esophageal cancer: implications for radiotherapy target delineation
por: Luo, Yijun, et al.
Publicado: (2017)

Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2016)

CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer
por: Zhu, Yingming, et al.
Publicado: (2016)

Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy
por: Wang, Xiaoli, et al.
Publicado: (2016)

18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
por: Zhu, Wenyao, et al.
Publicado: (2018)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
por: Kim, Kyung Su, et al.
Publicado: (2021)

Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
por: Wang, Yichun, et al.
Publicado: (2021)

Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer
por: Jing, Xuquan, et al.
Publicado: (2016)

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
por: Liu, Xuemei, et al.
Publicado: (2017)

The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes
por: Han, Dali, et al.
Publicado: (2016)

The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma
por: Dong, Xinzhe, et al.
Publicado: (2017)

A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma
por: Jin, Xing, et al.
Publicado: (2021)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma
por: Hou, Dong-Liang, et al.
Publicado: (2013)

Delineation of Radiation Therapy Target Volumes for Lingual Nerve Involvement
por: Sozio, Stephen J, et al.
Publicado: (2022)

Postoperative Radiotherapy for Glioma: Improved Delineation of the Clinical Target Volume Using the Geodesic Distance Calculation
por: Yan, DanFang, et al.
Publicado: (2014)

Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response
por: Wang, Zhe, et al.
Publicado: (2018)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT
por: Han, Dali, et al.
Publicado: (2019)

Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition
por: Yu, Jing, et al.
Publicado: (2019)

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume
por: Cui, Tiantian, et al.
Publicado: (2021)

Evaluation of delineating the target volume by radiation therapists in breast cancer patients
por: van Pelt, V.W.J., et al.
Publicado: (2021)

Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer
por: Liu, Jun, et al.
Publicado: (2017)

Is it necessary for clinical tumor volume including neck muscles in target volume delineation of nasopharyngeal carcinoma?
por: Chen, Fei, et al.
Publicado: (2021)

Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer
por: Koo, Taeryool, et al.
Publicado: (2022)

Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma
por: Bird, David, et al.
Publicado: (2015)

Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Shi, Yu, et al.
Publicado: (2019)

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2020)

The Predictive Value of Tumor Volume and Its Change on Short-Term Outcome for Esophageal Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
por: Liang, Shuai, et al.
Publicado: (2021)

The Prognostic Significance of Metastatic Nodal Size in Non-surgical Patients With Esophageal Squamous Cell Carcinoma
por: Zhao, Zongxing, et al.
Publicado: (2020)

The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma
por: Kaida, Hayato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0d2galndv21r5h0p7v761vrglg